Jakob Loven
InvestorManaging Partner at Nextech Invest
Zurich, Switzerland
Writes $100K – $5M checks · typically $1.5M
Contact· published on Jakob's own website
Experience
- Juvia GroupCo-Founder and Managing Partnercurrent2025 — presentEurope
- Nextech Invest Ltd.Managing Partner2017 — 2025Zurich, Switzerland
- IDRxBoard Observer2022 — 2024Boston, MA
- Hexagon BioBoard Member2021 — 2024San Francisco Bay Area
- Flare TherapeuticsBoard Member2021 — 2024Boston, MA
- IconOVir BioBoard Member2021 — 2024San Diego, CA
- Breakthrough PropertiesAdvisory Board2020 — 2024Zurich, Switzerland
- Arrakis TherapeuticsBoard Member2019 — 2024Greater Boston
- A2 Biotherapeutics, Inc.Board Member2018 — 2024Los Angeles Metropolitan Area
- Boundless BioBoard Member2021 — 2024San Diego, CA
- Vividion Therapeutics. Inc.Board Member2019 — 2021Greater San Diego Area
- Kronos Bio, Inc.Board Member2019 — 2021San Mateo, California
- Kinnate Biopharma, Inc.Board Observer2019 — 2021San Diego, California, United States
- ArvinasBoard Member2018 — 2020New Haven, CT
- Turning Point TherapeuticsBoard Observer2018 — 2019Greater San Diego Area
- Autolus Ltd.Board Observer2017 — 2018London, United Kingdom
- Relay TherapeuticsCo-Founder2016 — 2017Greater Boston Area
- Third Rock VenturesSenior Investment Proffesional2015 — 2017Greater Boston Area
- Swedish American Chamber of Commerce - New EnglandSenior Adviser, SACC Life Science Acclerator2013 — 2016Greater Boston Area
- Syros PharmaceuticalsCo-Founder2013 — 2015Greater Boston Area
- Whitehead InstitutePostdoctoral Fellow2010 — 2013Greater Boston Area
- Karolinska InstitutetPhD in Medical Sciences2005 — 2010Stockholm, Sweden
- AstraZenecaResearch Scientist2002 — 2005Lund, Sweden
- Swedish Armed ForcesConscript Officer and Boat Commander in the Swedish Royal Navy Special Forces1997 — 1999Vaxholm, Sweden
Skills & more
Cell40Cell Biology80Molecular Biology52In Vitro13Genomics36Bioinformatics22Systems Biology11Lifesciences10Drug Discovery41Biotechnology19Biomarker Discovery2Epigenomics9
+12 more
TranscriptionCancer BiologyRNA biologyDrug DevelopmentMolecular OncologyEpigeneticsBiomarkersBiochemistryPharmaceutical IndustryChromatin ImmunoprecipitationSequencingHigh Throughput ScreeningLanguages English · French · Spanish · Swedish
From Jakob's professional profile.
Colleagues at Nextech Invest
Network1
Investors connected to Jakob in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jakob Loven?
- Partner at Nextech Invest
- Where does Jakob Loven work?
- Jakob Loven is Managing Partner at Nextech Invest.
- What check size does Jakob Loven write?
- Jakob Loven typically writes checks of $100K – $5M.
- Where did Jakob Loven go to school?
- Jakob Loven studied at Karolinska Institutet (Doctor of Philosophy (Ph.D.), Medical Sciences); Anglia Ruskin University (Bachelor's degree, Biomedical Sciences); Sigtunaskolan Humanistiska Läroverket (SSHL) (International Baccalaureate, Natural Sciences).
Founder mafias
Third Rock Ventures mafia16
Also came through, then founded or led a company.
Reid HuberPartnerFounded MOMA Therapeutics +2Christoph LengauerPartnerFounded Celsius Therapeutics +2Steve PaulVenture PartnerFounded Voyager Therapeutics, Inc. +1Alexis BorisyPartnerFounded Foundation Medicine +1Philip ReillyVenture PartnerFounded Luna Genetics +1Abbie CelnikerPartnerFounded Eleven Biotherapeutics
+ 9 more
Karolinska Institutet mafia6
Also came through, then founded or led a company.
Carl-Johan DalsgaardDoctor of Medicine - MDFounded Vicore PharmaPadideh Kamali-ZareResearch AssistantFounded DarmiyanNicolas WertheimerInternshipFounded WaterplanKerstin JedingForskningsassistent vid Karolinska Institutet och IPMFounded PeakPathGabriel Ocana SanteroResearch InternFounded Exin Therapeutics
Anglia Ruskin University mafia3
Also came through, then founded or led a company.
Boundless Bio mafia3
Also came through, then founded or led a company.
Vividion Therapeutics mafia2
Also came through, then founded or led a company.
Same school
Also attended Karolinska Institutet29
Andreas LindblomManaging Partner at ScietyGunnar AhlbergVenture Partner at ScietyJohan LundVenture Partner at ScietyPatrik SobockiPractice Lead Deep Tech and Senior Investment Director at IndustrifondenJonathan IlickiInvestor at IndustrifondenElaine HuangTax Director at Tribe Capital Firstlook
+ 23 more
Also attended Anglia Ruskin University11
Christian BuergerPortfolio Development at Intel CapitalJonathan MilnerInvestor at Cambridge Innovation CapitalChris BarrandPrincipal at Level EquityMichaelFund Controller at Black SeedFranco PontilloGeneral Partner at DOMO.VCSogiInvestor at EHE Capital
+ 5 more
Also attended Sigtunaskolan Humanistiska Läroverket (SSHL)3
Shared employers
Also worked at Juvia Group1
Also worked at Nextech Invest Ltd.9
Richard HeymanVenture Partner at ARCH Venture PartnersStella PaffenholzSenior Associate at Atlas VentureAlexis BorisyOperating Chairman at Curie.BioGabriele CampiImmunologist / Technology Transfer at Aurora ScienceTeta AugeniaExecutive Assistant & Office Manager at AC VenturesKristina BeelerScientific Advisory Board; Chief Business Officer at Biognosys, PhD at Biovance Capital Partners SCR
+ 3 more
Also worked at Arrakis Therapeutics9
Alan WaltsVenture Partner at Advent Life SciencesNeil KubicaTherapeutics at GENERAL INCEPTIONRichard GasterManaging Partner at venBio PartnersSasa VucinicManaging Partner and Co-Founder at North Base MediaNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health Investors
+ 3 more
Also worked at Relay Therapeutics12
Anneli MathesonExecutive Assistant at Prelude VenturesJulia PianSenior Associate at Atlas VentureEli CasdinChief Investment Officer and Founder at Casdin CapitalDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesLauren DanielChief Compliance Officer and General Counsel at 5AM VenturesSteve KafkaGeneral Partner at S32
+ 6 more




























































